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 2 
ABSTRACT 25 
Aim: Respiratory failure secondary to pulmonary hypoplasia is the main cause of death in 26 
congenital diaphragmatic hernia (CDH). Lung growth is regulated by growth factors (GFs), 27 
whose imbalances is reported in pathological conditions. We measured amniotic fluid levels of 28 
GFs, regulating lung development, in pregnancies with CDH and compared them with normal 29 
gestations. 30 
Methods: Amniotic fluid was collected at amniocentesis and delivery from 4 women carrying  31 
fetuses with CDH and 12 with normal pregnancy. GFs were isolated and quantified. Same GFs 32 
were measured in lung biopsies collected during autopsy of 3 newborns dead of CDH. 33 
Results: Impairment expression of lung GFs in the amniotic fluid of CDH pregnancies in 34 
comparison with normal was found. FGF10, FGF7, VEGF and TGFβ were decreased at 35 
amniocentesis, while PDGF increased. While FGF10 and PDGF tended to normalize at delivery, 36 
EGF increased and TGFβ was still decreased. Same GFs were similarly expressed in both lungs 37 
of babies dead of CDH. 38 
Conclusion: Anomalies in lung GFs expression of embryos and fetuses with CDH can be 39 
detected by measuring their levels in the amniotic fluid during pregnancy. Further investigation 40 
would help to correlate prenatal expression of GFs and clinical outcome of babies with CDH 41 
after birth. 42 
43 
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INTRODUCTION 44 
Congenital diaphragmatic hernia (CDH) is a human malformation that causes high mortality in 45 
newborns, because of severe respiratory failure secondary to pulmonary hypoplasia and long-46 
term pulmonary morbidity in survivors. Although widely studied in the experimental model of 47 
CDH [1-4], the pathogenesis of lung hypoplasia associated with CDH remains unclear. The 48 
studies based on teratogenetic animal models of malformations may be criticized because it is 49 
not known whether the anomalies found are to direct effects of the chemical used or to the 50 
malformations induced by it. On the other hand, human studies are difficult to realize for ethical 51 
and technical reasons. Lung development is regulated by complex tissue interactions mediated 52 
by growth factors that promotes cell proliferation and differentiation, such as FGF, EGF, VEGF 53 
and PDGF, and others that oppose these effects, such as TGFβ [5]. Their imbalances have 54 
been reported in various pathological lung conditions [6]. As growth factors are diffusible 55 
proteins, we hypothesized that abnormal expression of growth factors that regulate lung 56 
development may be reflected in a different concentration of the same proteins in the amniotic 57 
fluid during pregnancy. 58 
The purpose of this study is to gain further insight the role of lung growth factors in the 
59 
pathogenesis of pulmonary hypoplasia in CDH and to explore the possibility of identifying 
60 
prenatal predictive values of the clinical outcome of newborns with CDH.  
61 
 
62 
63 
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MATERIAL AND METHODS 64 
Study groups: After approval by the Institutional Research Commitee (licence number: 65 
22-11), all women with a spontaneous pregnancy, in which an advanced-level ultrasound (US), 66 
performed in our Institution between August 2011 and December 2012, revealed CDH and 67 
amniocentesis was indicated, were enrolled in the cases group (A). Twelve women with a 68 
spontaneous pregnancy and a routine anatomy US without anomalies who performed 69 
amniocentesis, as per advice based on maternal age or as per maternal decision, in our 70 
Institution in the same period of time, were randomly enrolled in the controls group (B).  71 
Demographic characteristics, obstetrical variables such as parity, women habits during 72 
pregnancy, mode of delivery, obstetrical complications, indication of amniocentesis and 73 
gestational age when it was accomplished, fetal karyotype, newborn data such as weight and 74 
general conditions at birth were collected. 75 
ELISA analysis in the amniotic fluid: The supernatant of the centrifuged amniotic fluid 76 
collected at amniocentesis was snap-frozen and stored at -80°C. 77 
At delivery, 20 ml of amniotic fluid were collected in both groups from the amniotic cavity without 78 
contamination with maternal blood. The supernatant was snap-frozen and stored at -80°C. The 79 
samples contaminated with blood were discarded.  80 
After assessing the protein content of the amniotic fluid collected during amniocentesis and 81 
delivery with the Lowry protein assay (Sigma, Trieste, Italy) and calibrating the samples to 82 
enable a balanced comparison between groups, fibroblast growth factor 10 (FGF10), fibroblast 83 
growth factor 7 (FGF7), epidermal growth factors (EGF), vascular endothelial growth factor 84 
(VEGF), platelet-derived growth factor (PDGF) and transforming growth factor β (TGFβ) levels 85 
were quantified using ELISA kits (Tema Ricerca ref: CSB-E14965H, RAY-ELH-FGF7-001, RAY-86 
ELH-EGF-001, EH2VEGF, CSB-E04701H, EIA-1864, Bologna, Italy) in both groups of pregnant 87 
women. Concentration of amniotic fluid growth factors were expressed in pg/ml. 88 
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ELISA analysis in lung biopsies: Biopsies from both lungs were collected during autopsy 89 
of newborns who had died of CDH. The lung tissue was homogenized in lysis buffer (1 mmol/l 90 
sodium vanate; 1% SDS; 0.01 mol/l Tris-HCl, pH 7.4) with protease inhibitors. The protein 91 
content was assessed using the Lowry protein assay (Sigma, Trieste, Italy). FGF10, FGF7, 92 
EGF, VEGF, PDGF and TGFβ levels were quantified by ELISA (Tema Ricerca ref: CSB-93 
E14965H, RAY-ELH-FGF7-001, RAY-ELH-EGF-001, EH2VEGF, CSB-E04701H, EIA-1864, 94 
Bologna, Italy). All procedures were carried out strictly following the instruction offered with the 95 
ELISA kit. Concentration of lung growth factors were expressed in pg/ml. 96 
Statistical methods: The results were expressed as percentages or as means±SD and 97 
the groups were compared by Anova tests with a threshold of significance at p<0.05. Tukey’s 98 
range test was used as post-hoc test.  99 
 100 
101 
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RESULTS 102 
Study groups data: Between August 2011 and December 2012, the advanced-level US 103 
confirmed in 4 women the diagnosis of left CDH.  104 
The mean maternal age of the study group (A) was 30.25 years, being two of them 22 and 23 105 
years old, while the others 38 years old. All women were Caucasian. Three of them were 106 
nulliparous, two of them had one previous miscarriage. None of them smoked or drank alcohol 107 
during pregnancy. None of them had problems of obesity. All of them had unlabored elective 108 
cesarean deliveries at term (mean 38 weeks) and the procedure was performed without 109 
complications. Gestational age mean at the time of amniocentesis was  18 weeks. The fetal 110 
karyotype was 46,XY in all cases without any chromosomal abnormalities. The mean weight of 111 
the newborns was 2.8 kg (Table 1). In all newborns the diagnosis of left CDH was confirmed at 112 
birth. They were intubated immediately after birth and high-frequency oscillatory ventilation was 113 
started.  114 
The mean maternal age of the control group (B) was 37.5 years. All women were Caucasian. 115 
Five of them were nulliparous, four of them had previous miscarriages (3 in one woman, 2 in 116 
another and 1 in the remaining two). None of them smoked or drank alcohol during pregnancy. 117 
None of them had problems of obesity. All of them had unlabored elective cesarean deliveries at 118 
term (mean 39 weeks) and the procedure was performed without complications. Advanced 119 
maternal age was the most frequent indication for amniocentesis. Gestational age mean at the 120 
time of amniocentesis was 17 weeks. The fetal karyotype was 46,XY in 6 cases and 46,XX in 121 
the remaining, without chromosomal abnormalities in all of them. The mean weight of the 122 
newborns was 3.3 kg (Table 1). All the newborns were healthy at birth and had no respiratory 123 
problems. 124 
No significant differences were found among the groups with respect to parity, habits during 125 
pregnancy, mode of delivery, obstetrical complications, gestational age at amniocentesis and 126 
newborn weight. 127 
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ELISA analysis in the amniotic fluid: Growth factors were detectable in most but not all 128 
amniotic fluid samples. All samples of amniotic fluid collected at delivery in women with a fetus 129 
with CDH had no detectable levels of FGF7 and VEGF. Also the samples of amniotic fluid from 130 
delivery of normal pregnancies showed no VEGF (Figure 1 B and E). 131 
When FGF10 was quantified, decreased levels were noted in amniotic fluid of CDH 132 
pregnancies at both endpoints, even if the difference was not significant. FGF10 was the most 133 
concentrated growth factor both at the time of amniocentesis and delivery in all pregnancies 134 
(Figure 1 A).  135 
A similar trend of decrement was seen in FGF7 levels of amniotic fluid from CDH 136 
pregnancies at amniocentesis. At the end of the pregnancy, FGF7 was lower in control amniotic 137 
fluid and no detectable in CDH pregnancies (Figure 1 B). 138 
The levels of EGF were very low in both groups at the time of second trimester 139 
amniocentesis. At delivery, EGF significantly increased in pregnancies with CDH in comparison 140 
with controls (Figure 1 C). 141 
PDGF was significantly increased in the second trimester CDH amniotic fluid in 142 
comparison with controls, while its levels decreased at the end of the pregnancies and were very 143 
similar in CDH and control amniotic fluid (Figure 1 D). 144 
VEGF significantly decreased in the CDH second trimester pregnancies. VEGF was the 145 
less concentrated growth factor both at the time of amniocentesis and delivery in all pregnancies 146 
(Figure 1 E). 147 
TGFβ levels were significantly decreased in the amniotic fluid of CDH pregnancies both 148 
at amniocentesis and at delivery (Figure 1 F). 149 
The levels of the growth factors showed neither any consistency nor any statistically 150 
significant association with parity, gestational age at amniocentesis and newborn weight.  151 
ELISA analysis in lung biopsies: Three of the babies born with left CDH died in the first 152 
week of life due to the impossibility to achieve the physiological stabilization. Lung biopsies were 153 
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collected at autopsy. Growth factors were detectable in all lung samples. Interestingly, no 154 
significant differences were found in the expression of lung growth factors in the right and the left 155 
lung in all cases. EGF had the lowest concentration in both lungs, while VEGF the highest. 156 
FGF10 and FGF7 had concentration lower than 100 pg/ml  (Figure 2).   157 
 158 
159 
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DISCUSSION 160 
Congenital diaphragmatic hernia is a malformation that still causes high mortality in newborns 161 
mainly because of severe respiratory failure secondary to pulmonary hypoplasia. The 162 
pathogenesis of lung hypoplasia has not been fully understood. It has been suggested that the 163 
abnormalities in bronchial innervation described in infants with CDH [1] might contribute to the 164 
pulmonary developmental deficiency. The role fulfilled by neural tissue in early gestation seems 165 
to be secretion of trophic factors for the smooth muscle that indirectly contributes to lung 166 
development. In fact, it has been proposed that the smooth muscle spontaneous contractions 167 
produce a rhythmic mechanical stimulus across the airway wall and the adjacent parenchyma 168 
that contributes to normal airway differentiation and branching by inducing expression of growth 169 
factors [7,8].   170 
Given these observations, we expected that the expression of the growth factors that regulate 171 
branching and control airway size and cell fate in the developing lung may be impaired in 172 
fetuses and infants with CDH. Lung development is the result of the balanced action of growth 173 
factors that promotes cell proliferation and differentiation, such as FGF, EGF, VEGF and PDGF, 174 
and others that oppose these effects, such as TGFβ. At the end of development, these signals 175 
maintain cellular activities at equilibrium and preserve normal lung structure and function  [5,9]. 176 
Abnormal expression of these factors and their inappropriate signalling activation cause 177 
pathological lung condition. Growth factors are diffusible proteins and we hypothesized that their 178 
abnormal expression may be reflected in a different concentration of them in the amniotic fluid 179 
during pregnancy. Therefore, we determined the concentration of lung growth factors in the 180 
amniotic fluid at amniocentesis and at delivery in pregnancies with a diagnosis of CDH and 181 
compared them with normal pregnancies. We considered a panel of growth factors involved in 182 
all phases of lung development in an attempt to highlight specific abnormalities in the process of 183 
lung formation. We could enroll only four cases in the study group during the study period. 184 
Despite this, the two groups were not significantly different with respect to parity, habits during 185 
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pregnancy, mode of delivery, obstetrical complications, gestational age at amniocentesis and 186 
newborn weight.  187 
Growth factors were not detectable in all amniotic fluid samples. Surprisingly, we could not find 188 
VEGF in the amniotic fluid of delivery both in CDH and normal pregnancies. The absence of 189 
VEGF in samples of amniotic fluid has been previously reported [10]. VEGF is a strong promoter 190 
of angiogenesis and its signalling is responsible for the differentiation of embryonic 191 
mesenchymal cells into endothelial cells; the interaction between the epithelium and the 192 
mesenchyme contribute to lung neovascularisation that is crucial in normal lung development 193 
[9,11,12]. The concentration of VEGF was significantly decreased in the amniotic fluid from 194 
amniocentesis performed in women carrying a fetus with CDH. It is well known that the 195 
development of vascular bed is defective in CDH [13]. Although VEGF is not only expressed in 196 
the lung, its lower levels could account for the decreased number of vessels per unit in CDH 197 
lung. 198 
FGF10 is essential for lung branching morphogenesis having a central role in inducing the 199 
spatial coordinates for patterning the epithelial tubules [5]. The FGF10 levels were decreased in 200 
the amniotic fluid of CDH pregnancies at the time of amniocentesis and tended to normalize at 201 
the end of pregnancy. FGF7 promotes epithelial growth and citodifferentiation and it is 202 
expressed at highest levels at late stages [5]. FGF7 had decreased levels at amniocentesis and 203 
was not detectable at delivery in the amniotic fluid of pregnancies with CDH. Both findings were 204 
consistent with the hypothesis that the lung development is delayed in animals and infants with 205 
CDH [1]. On the other hand, EGF levels were significantly increased at term in pregnancies with 206 
CDH. EGF positively modulates embryonic lung branching morphogenesis and regulates type 2 207 
alveolar cell proliferation [5] and our result could be either the consequence of the delayed in 208 
lung development or an attempt to compensate the lower levels of FGF family proteins. A similar 209 
intent to counteract the decreased expression of growth factors which promote branching, could 210 
be seen in the increased values of EGF and PDGF at the time of delivery. PDGF signalling 211 
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regulates epithelial DNA synthesis and early branching during embryonic life and it is essential 212 
for the ontogeny of pulmonary alveolar myofibroblasts, elastin synthesis and hence 213 
alveolarization in postnatal life [5]. 214 
TGFβ opposes FGF and EGF effects preventing local budding and maintaining proximal airways 215 
in an unbranched form by suppressing epithelial cell proliferation and by promoting synthesis of 216 
extracellular matrix components around airways. Its levels were significantly decreased in the 217 
amniotic fluid of CDH pregnancies at both endpoints. This finding could support the idea that 218 
lung development is delayed in CDH and therefore TGFβ concentration is still low when a 219 
normal lung development needs it to increase.  220 
In conclusion, the expression of lung growth factors is impaired in the amniotic fluid of CDH 221 
pregnancies in terms of decreased levels of proteins that regulate the branching or high levels of 222 
proteins that modulate early branching when the corresponding control values have already go 223 
down. At the same time the levels of growth factors were similar in both lungs of newborns dead 224 
of CDH. The fact that the lung ipsilateral and the contralateral to the hernia were equally affected 225 
is consistent with the pattern of lung innervation abnormalities found in infants with CDH [1] and 226 
further supports the concept of pulmonary hypoplasia as a primary developmental defect rather 227 
than the result of lung compression during development. 228 
The present study has several weak points that should be acknowledged. In the first place, the 229 
reduced number of CDH pregnancies weakens our conclusion and invites further confirmation of 230 
our findings in the future. Moreover, the lack of a control group to compare the results of lung 231 
biopsies analysis led us to hypothetical speculations about their being different from the control. 232 
Third, the management during resuscitation and ventilation of CDH newborns might have 233 
affected the expression of lung growth factors. Forth, we were not able to correlate prenatal 234 
expression of the growth factors and clinical outcome of the babies after birth because the 235 
management was different for each patient. Collection of more specimens is desirable to 236 
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investigate if the levels of some of the growth factors could be a predictor of the entity of 237 
postnatal lung deficiency in babies with CDH. 238 
Nevertheless, our results demonstrate an impairment in lung growth factors expression of 239 
embryos and fetuses with CDH, which can be detected by measuring their levels in the amniotic 240 
fluid during pregnancy.   241 
 242 
243 
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LIST OF ABBREVIATIONS 247 
CDH: congenital diaphragmatic hernia  248 
EGF: epidermal growth factors 249 
ELISA: Enzyme-Linked ImmunoSorbent Assay  250 
FGF7: fibroblast growth factor 7 251 
FGF10: fibroblast growth factor 10  252 
GF: growth factors 253 
PDGF: platelet-derived growth factor 254 
VEGF: vascular endothelial growth factor 255 
TGFβ: transforming growth factor β 256 
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LEGEND FOR THE TABLE 294 
Table 1 295 
Control and study groups data. 296 
 297 
LEGEND FOR THE FIGURES 298 
Figure 1 299 
Amniotic fluid levels of FGF10 (A), FGF7 (B), EGF (C), PDGF (D), VEGF (E) and TGFb (F) at 300 
the time of amniocentesis and delivery in pregnancies with a fetus with CDH and in normal ones 301 
(# p<0.05 vs control of the same endpoint).  302 
Figure 2 303 
Lung levels of FGF10 (A), FGF7 (B), EGF (C), PDGF (D), VEGF (E) and TGFb (F) in right and 304 
left lung of babies dead of CDH (# p<0.05 vs control).  305 
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